APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026

Report ID 174227830415 April 2026Not stated

Choose your research edition.

Industry ResearchRecombinant Protein Production Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Production Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Production Service Market Analysis and Forecast 2026-2032221 pages · $4,950 USD

Market perspective

The global Recombinant Protein Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Protein Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Protein Production Service market include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech and Leinco Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Recombinant Protein Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Protein Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Protein Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Recombinant Protein Production Service market.

Recombinant Protein Production Service Segment by Company

Charles River

Biomatik

R&D Systems

Applied Biological Materials Inc. (abm)

VectorBuilder

BiologicsCorp

Proteos

RayBiotech

Leinco Technologies

Kinexus Bioinformatics

InVivo BioTech Services GmbH

Expression Systems

Creative Biolabs

G &P Biosciences

Eurofins Discovery

Levprot Bioscience

eEnzyme

NorthX Biologics

Jubilant Biosys

GenScript

Boster Bio

Sino Biological

WuXi Biologic

CUSABIO TECHNOLOGY

Recombinant Protein Production Service Segment by Type

Mammalian Cell Based

Bacteria Based

Insect Cell Based

Others

Recombinant Protein Production Service Segment by Application

Biomedicine

Industrial Biotechnology

Therapeutics

Others

Recombinant Protein Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Protein Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Recombinant Protein Production Service key companies, revenue, market share, and recent developments.

3. To split the Recombinant Protein Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Recombinant Protein Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Protein Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Protein Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Protein Production Service industry.

Chapter 3: Detailed analysis of Recombinant Protein Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Recombinant Protein Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Recombinant Protein Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Protein Production Service Industry Trends Table 2. Recombinant Protein Production Service Industry Drivers Table 3. Recombinant Protein Production Service Industry Opportunities and Challenges Table 4. Recombinant Protein Production Service Industry Restraints Table 5. Global Recombinant Protein Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Protein Production Service Revenue Share by Company (2021-2026) Table 7. Global Recombinant Protein Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Recombinant Protein Production Service Key Company Manufacturing Base & Headquarters Table 9. Global Recombinant Protein Production Service Company, Product Type & Application Table 10. Global Recombinant Protein Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Recombinant Protein Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mammalian Cell Based Table 15. Significant Companies of Bacteria Based Table 16. Significant Companies of Insect Cell Based Table 17. Significant Companies of Others Table 18. Global Recombinant Protein Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Recombinant Protein Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Recombinant Protein Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Recombinant Protein Production Service Sales Value Share by Type (2021-2026) Table 22. Global Recombinant Protein Production Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biomedicine Table 24. Significant Companies of Industrial Biotechnology Table 25. Significant Companies of Therapeutics Table 26. Significant Companies of Others Table 27. Global Recombinant Protein Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Recombinant Protein Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Recombinant Protein Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Recombinant Protein Production Service Sales Value Share by Application (2021-2026) Table 31. Global Recombinant Protein Production Service Sales Value Share by Application (2027-2032) Table 32. Global Recombinant Protein Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Recombinant Protein Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Recombinant Protein Production Service Sales Value Share by Region (2021-2026) Table 35. Global Recombinant Protein Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Recombinant Protein Production Service Sales Value Share by Region (2027-2032) Table 37. Global Recombinant Protein Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Recombinant Protein Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Recombinant Protein Production Service Sales Value Market Share by Country (2021-2026) Table 40. Global Recombinant Protein Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Recombinant Protein Production Service Sales Value Market Share by Country (2027-2032) Table 42. Charles River Company Information Table 43. Charles River Business Overview Table 44. Charles River Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Charles River Recombinant Protein Production Service Product Portfolio Table 46. Charles River Recent Development Table 47. Biomatik Company Information Table 48. Biomatik Business Overview Table 49. Biomatik Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Biomatik Recombinant Protein Production Service Product Portfolio Table 51. Biomatik Recent Development Table 52. R&D Systems Company Information Table 53. R&D Systems Business Overview Table 54. R&D Systems Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. R&D Systems Recombinant Protein Production Service Product Portfolio Table 56. R&D Systems Recent Development Table 57. Applied Biological Materials Inc. (abm) Company Information Table 58. Applied Biological Materials Inc. (abm) Business Overview Table 59. Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio Table 61. Applied Biological Materials Inc. (abm) Recent Development Table 62. VectorBuilder Company Information Table 63. VectorBuilder Business Overview Table 64. VectorBuilder Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. VectorBuilder Recombinant Protein Production Service Product Portfolio Table 66. VectorBuilder Recent Development Table 67. BiologicsCorp Company Information Table 68. BiologicsCorp Business Overview Table 69. BiologicsCorp Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. BiologicsCorp Recombinant Protein Production Service Product Portfolio Table 71. BiologicsCorp Recent Development Table 72. Proteos Company Information Table 73. Proteos Business Overview Table 74. Proteos Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Proteos Recombinant Protein Production Service Product Portfolio Table 76. Proteos Recent Development Table 77. RayBiotech Company Information Table 78. RayBiotech Business Overview Table 79. RayBiotech Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. RayBiotech Recombinant Protein Production Service Product Portfolio Table 81. RayBiotech Recent Development Table 82. Leinco Technologies Company Information Table 83. Leinco Technologies Business Overview Table 84. Leinco Technologies Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Leinco Technologies Recombinant Protein Production Service Product Portfolio Table 86. Leinco Technologies Recent Development Table 87. Kinexus Bioinformatics Company Information Table 88. Kinexus Bioinformatics Business Overview Table 89. Kinexus Bioinformatics Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio Table 91. Kinexus Bioinformatics Recent Development Table 92. InVivo BioTech Services GmbH Company Information Table 93. InVivo BioTech Services GmbH Business Overview Table 94. InVivo BioTech Services GmbH Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio Table 96. InVivo BioTech Services GmbH Recent Development Table 97. Expression Systems Company Information Table 98. Expression Systems Business Overview Table 99. Expression Systems Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Expression Systems Recombinant Protein Production Service Product Portfolio Table 101. Expression Systems Recent Development Table 102. Creative Biolabs Company Information Table 103. Creative Biolabs Business Overview Table 104. Creative Biolabs Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Creative Biolabs Recombinant Protein Production Service Product Portfolio Table 106. Creative Biolabs Recent Development Table 107. G &P Biosciences Company Information Table 108. G &P Biosciences Business Overview Table 109. G &P Biosciences Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. G &P Biosciences Recombinant Protein Production Service Product Portfolio Table 111. G &P Biosciences Recent Development Table 112. Eurofins Discovery Company Information Table 113. Eurofins Discovery Business Overview Table 114. Eurofins Discovery Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Eurofins Discovery Recombinant Protein Production Service Product Portfolio Table 116. Eurofins Discovery Recent Development Table 117. Levprot Bioscience Company Information Table 118. Levprot Bioscience Business Overview Table 119. Levprot Bioscience Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Levprot Bioscience Recombinant Protein Production Service Product Portfolio Table 121. Levprot Bioscience Recent Development Table 122. eEnzyme Company Information Table 123. eEnzyme Business Overview Table 124. eEnzyme Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. eEnzyme Recombinant Protein Production Service Product Portfolio Table 126. eEnzyme Recent Development Table 127. NorthX Biologics Company Information Table 128. NorthX Biologics Business Overview Table 129. NorthX Biologics Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. NorthX Biologics Recombinant Protein Production Service Product Portfolio Table 131. NorthX Biologics Recent Development Table 132. Jubilant Biosys Company Information Table 133. Jubilant Biosys Business Overview Table 134. Jubilant Biosys Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Jubilant Biosys Recombinant Protein Production Service Product Portfolio Table 136. Jubilant Biosys Recent Development Table 137. GenScript Company Information Table 138. GenScript Business Overview Table 139. GenScript Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. GenScript Recombinant Protein Production Service Product Portfolio Table 141. GenScript Recent Development Table 142. Boster Bio Company Information Table 143. Boster Bio Business Overview Table 144. Boster Bio Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Boster Bio Recombinant Protein Production Service Product Portfolio Table 146. Boster Bio Recent Development Table 147. Sino Biological Company Information Table 148. Sino Biological Business Overview Table 149. Sino Biological Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Sino Biological Recombinant Protein Production Service Product Portfolio Table 151. Sino Biological Recent Development Table 152. WuXi Biologic Company Information Table 153. WuXi Biologic Business Overview Table 154. WuXi Biologic Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. WuXi Biologic Recombinant Protein Production Service Product Portfolio Table 156. WuXi Biologic Recent Development Table 157. CUSABIO TECHNOLOGY Company Information Table 158. CUSABIO TECHNOLOGY Business Overview Table 159. CUSABIO TECHNOLOGY Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio Table 161. CUSABIO TECHNOLOGY Recent Development Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Recombinant Protein Production Service Product Image Figure 2. Global Recombinant Protein Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Protein Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mammalian Cell Based Image Figure 8. Bacteria Based Image Figure 9. Insect Cell Based Image Figure 10. Others Image Figure 11. Global Recombinant Protein Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Recombinant Protein Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Protein Production Service Sales Value Share by Type (2021-2032) Figure 14. Biomedicine Image Figure 15. Industrial Biotechnology Image Figure 16. Therapeutics Image Figure 17. Others Image Figure 18. Global Recombinant Protein Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Recombinant Protein Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Recombinant Protein Production Service Sales Value Share by Application (2021-2032) Figure 21. Global Recombinant Protein Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Recombinant Protein Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Mammalian Cell Based
  • Bacteria Based
  • Insect Cell Based
  • Others
Applications
  • Biomedicine
  • Industrial Biotechnology
  • Therapeutics
  • Others
Companies covered
  • Charles River
  • Biomatik
  • R&D Systems
  • Applied Biological Materials Inc. (abm)
  • VectorBuilder
  • BiologicsCorp
  • Proteos
  • RayBiotech
  • Leinco Technologies
  • Kinexus Bioinformatics
  • InVivo BioTech Services GmbH
  • Expression Systems
  • Creative Biolabs
  • G &P Biosciences
  • Eurofins Discovery
  • Levprot Bioscience
  • eEnzyme
  • NorthX Biologics
  • Jubilant Biosys
  • GenScript
  • Boster Bio
  • Sino Biological
  • WuXi Biologic
  • CUSABIO TECHNOLOGY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Protein Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Protein Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Recombinant Protein Production Service Market Dynamics
  1. 2.1 Recombinant Protein Production Service Industry Trends
  2. 2.2 Recombinant Protein Production Service Industry Drivers
  3. 2.3 Recombinant Protein Production Service Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Production Service Industry Restraints
3 Recombinant Protein Production Service Market by Company
  1. 3.1 Global Recombinant Protein Production Service Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Protein Production Service Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Protein Production Service Company Ranking (2024-2026)
  4. 3.4 Global Recombinant Protein Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Recombinant Protein Production Service Company Product Type and Application
  6. 3.6 Global Recombinant Protein Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Recombinant Protein Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Recombinant Protein Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Recombinant Protein Production Service Market by Type
  1. 4.1 Recombinant Protein Production Service Type Introduction
  2. 4.1.1 Mammalian Cell Based
  3. 4.1.2 Bacteria Based
  4. 4.1.3 Insect Cell Based
  5. 4.1.4 Others
  6. 4.2 Global Recombinant Protein Production Service Sales Value by Type
  7. 4.2.1 Global Recombinant Protein Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Recombinant Protein Production Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Recombinant Protein Production Service Sales Value Share by Type (2021-2032)
5 Recombinant Protein Production Service Market by Application
  1. 5.1 Recombinant Protein Production Service Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Industrial Biotechnology
  4. 5.1.3 Therapeutics
  5. 5.1.4 Others
  6. 5.2 Global Recombinant Protein Production Service Sales Value by Application
  7. 5.2.1 Global Recombinant Protein Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Recombinant Protein Production Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Recombinant Protein Production Service Sales Value Share by Application (2021-2032)
6 Recombinant Protein Production Service Regional Value Analysis
  1. 6.1 Global Recombinant Protein Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Protein Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Recombinant Protein Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Recombinant Protein Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Protein Production Service Sales Value (2021-2032)
  7. 6.3.2 North America Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Recombinant Protein Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Recombinant Protein Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Recombinant Protein Production Service Sales Value (2021-2032)
  16. 6.6.2 South America Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Recombinant Protein Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
7 Recombinant Protein Production Service Country-level Value Analysis
  1. 7.1 Global Recombinant Protein Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Protein Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Recombinant Protein Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Recombinant Protein Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Recombinant Protein Production Service Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Biomatik
  8. 8.2.1 Biomatik Company Information
  9. 8.2.2 Biomatik Business Overview
  10. 8.2.3 Biomatik Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biomatik Recombinant Protein Production Service Product Portfolio
  12. 8.2.5 Biomatik Recent Developments
  13. 8.3 R&D Systems
  14. 8.3.1 R&D Systems Company Information
  15. 8.3.2 R&D Systems Business Overview
  16. 8.3.3 R&D Systems Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 R&D Systems Recombinant Protein Production Service Product Portfolio
  18. 8.3.5 R&D Systems Recent Developments
  19. 8.4 Applied Biological Materials Inc. (abm)
  20. 8.4.1 Applied Biological Materials Inc. (abm) Company Information
  21. 8.4.2 Applied Biological Materials Inc. (abm) Business Overview
  22. 8.4.3 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio
  24. 8.4.5 Applied Biological Materials Inc. (abm) Recent Developments
  25. 8.5 VectorBuilder
  26. 8.5.1 VectorBuilder Company Information
  27. 8.5.2 VectorBuilder Business Overview
  28. 8.5.3 VectorBuilder Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VectorBuilder Recombinant Protein Production Service Product Portfolio
  30. 8.5.5 VectorBuilder Recent Developments
  31. 8.6 BiologicsCorp
  32. 8.6.1 BiologicsCorp Company Information
  33. 8.6.2 BiologicsCorp Business Overview
  34. 8.6.3 BiologicsCorp Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BiologicsCorp Recombinant Protein Production Service Product Portfolio
  36. 8.6.5 BiologicsCorp Recent Developments
  37. 8.7 Proteos
  38. 8.7.1 Proteos Company Information
  39. 8.7.2 Proteos Business Overview
  40. 8.7.3 Proteos Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Proteos Recombinant Protein Production Service Product Portfolio
  42. 8.7.5 Proteos Recent Developments
  43. 8.8 RayBiotech
  44. 8.8.1 RayBiotech Company Information
  45. 8.8.2 RayBiotech Business Overview
  46. 8.8.3 RayBiotech Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RayBiotech Recombinant Protein Production Service Product Portfolio
  48. 8.8.5 RayBiotech Recent Developments
  49. 8.9 Leinco Technologies
  50. 8.9.1 Leinco Technologies Company Information
  51. 8.9.2 Leinco Technologies Business Overview
  52. 8.9.3 Leinco Technologies Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Leinco Technologies Recombinant Protein Production Service Product Portfolio
  54. 8.9.5 Leinco Technologies Recent Developments
  55. 8.10 Kinexus Bioinformatics
  56. 8.10.1 Kinexus Bioinformatics Company Information
  57. 8.10.2 Kinexus Bioinformatics Business Overview
  58. 8.10.3 Kinexus Bioinformatics Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio
  60. 8.10.5 Kinexus Bioinformatics Recent Developments
  61. 8.11 InVivo BioTech Services GmbH
  62. 8.11.1 InVivo BioTech Services GmbH Company Information
  63. 8.11.2 InVivo BioTech Services GmbH Business Overview
  64. 8.11.3 InVivo BioTech Services GmbH Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio
  66. 8.11.5 InVivo BioTech Services GmbH Recent Developments
  67. 8.12 Expression Systems
  68. 8.12.1 Expression Systems Company Information
  69. 8.12.2 Expression Systems Business Overview
  70. 8.12.3 Expression Systems Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Expression Systems Recombinant Protein Production Service Product Portfolio
  72. 8.12.5 Expression Systems Recent Developments
  73. 8.13 Creative Biolabs
  74. 8.13.1 Creative Biolabs Company Information
  75. 8.13.2 Creative Biolabs Business Overview
  76. 8.13.3 Creative Biolabs Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Creative Biolabs Recombinant Protein Production Service Product Portfolio
  78. 8.13.5 Creative Biolabs Recent Developments
  79. 8.14 G &P Biosciences
  80. 8.14.1 G &P Biosciences Company Information
  81. 8.14.2 G &P Biosciences Business Overview
  82. 8.14.3 G &P Biosciences Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 G &P Biosciences Recombinant Protein Production Service Product Portfolio
  84. 8.14.5 G &P Biosciences Recent Developments
  85. 8.15 Eurofins Discovery
  86. 8.15.1 Eurofins Discovery Company Information
  87. 8.15.2 Eurofins Discovery Business Overview
  88. 8.15.3 Eurofins Discovery Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eurofins Discovery Recombinant Protein Production Service Product Portfolio
  90. 8.15.5 Eurofins Discovery Recent Developments
  91. 8.16 Levprot Bioscience
  92. 8.16.1 Levprot Bioscience Company Information
  93. 8.16.2 Levprot Bioscience Business Overview
  94. 8.16.3 Levprot Bioscience Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Levprot Bioscience Recombinant Protein Production Service Product Portfolio
  96. 8.16.5 Levprot Bioscience Recent Developments
  97. 8.17 eEnzyme
  98. 8.17.1 eEnzyme Company Information
  99. 8.17.2 eEnzyme Business Overview
  100. 8.17.3 eEnzyme Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 eEnzyme Recombinant Protein Production Service Product Portfolio
  102. 8.17.5 eEnzyme Recent Developments
  103. 8.18 NorthX Biologics
  104. 8.18.1 NorthX Biologics Company Information
  105. 8.18.2 NorthX Biologics Business Overview
  106. 8.18.3 NorthX Biologics Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 NorthX Biologics Recombinant Protein Production Service Product Portfolio
  108. 8.18.5 NorthX Biologics Recent Developments
  109. 8.19 Jubilant Biosys
  110. 8.19.1 Jubilant Biosys Company Information
  111. 8.19.2 Jubilant Biosys Business Overview
  112. 8.19.3 Jubilant Biosys Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Jubilant Biosys Recombinant Protein Production Service Product Portfolio
  114. 8.19.5 Jubilant Biosys Recent Developments
  115. 8.20 GenScript
  116. 8.20.1 GenScript Company Information
  117. 8.20.2 GenScript Business Overview
  118. 8.20.3 GenScript Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 GenScript Recombinant Protein Production Service Product Portfolio
  120. 8.20.5 GenScript Recent Developments
  121. 8.21 Boster Bio
  122. 8.21.1 Boster Bio Company Information
  123. 8.21.2 Boster Bio Business Overview
  124. 8.21.3 Boster Bio Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Boster Bio Recombinant Protein Production Service Product Portfolio
  126. 8.21.5 Boster Bio Recent Developments
  127. 8.22 Sino Biological
  128. 8.22.1 Sino Biological Company Information
  129. 8.22.2 Sino Biological Business Overview
  130. 8.22.3 Sino Biological Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sino Biological Recombinant Protein Production Service Product Portfolio
  132. 8.22.5 Sino Biological Recent Developments
  133. 8.23 WuXi Biologic
  134. 8.23.1 WuXi Biologic Company Information
  135. 8.23.2 WuXi Biologic Business Overview
  136. 8.23.3 WuXi Biologic Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 WuXi Biologic Recombinant Protein Production Service Product Portfolio
  138. 8.23.5 WuXi Biologic Recent Developments
  139. 8.24 CUSABIO TECHNOLOGY
  140. 8.24.1 CUSABIO TECHNOLOGY Company Information
  141. 8.24.2 CUSABIO TECHNOLOGY Business Overview
  142. 8.24.3 CUSABIO TECHNOLOGY Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio
  144. 8.24.5 CUSABIO TECHNOLOGY Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst